Jean Pierre Olivier

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.

B Chevallier, Henri Roché, Jean Pierre Olivier et al. · PubMed · 1993 · 269 citations

Surgical Oncology, Breast Oncology, Immunology +19

Inflammatory Breast Cancer

Bernard Chevallier, Henri Roché, Jean Pierre Olivier et al. · American Journal of Clinical Oncology · 1993 · 241 citations

Surgical Oncology, Breast Oncology, Pathology +18

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.

B Chevallier, P. Chollet, Yacine Merrouche et al. · Journal of Clinical Oncology · 1995 · 124 citations

Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

E García-Giralt, Y Aymé, Michel Carton et al. · Breast Cancer Research and Treatment · 1992 · 34 citations

Medroxyprogesterone Acetate, Breast Oncology, Medicine +12

5-Fluorouracil versus 5-fluorouracil plus α-interferon as treatment of metastatic colorectal carcinoma. A randomized study

P. Dufour, Fares Husseini, Brian Dreyfus et al. · Annals of Oncology · 1996 · 28 citations

Gastrointestinal Oncology, Medicine, Randomized Study +7